Stallergenes Group

GPTKB entity

Properties (59)
Predicate Object
gptkbp:instanceOf gptkb:Company
gptkbp:acquisition gptkb:Stallergenes_Greer
gptkbp:aimsTo reduce allergy symptoms
gptkbp:collaborates_with universities
gptkbp:dedicatedTo scientific research
improving healthcare outcomes
gptkbp:develops customized allergy treatments
gptkbp:employs scientists
gptkbp:engagements market research
gptkbp:founded 1960
gptkbp:has_a gptkb:North_America
customer service
distributors
gptkbp:has_a_focus_on research and development
patient engagement
patient-centered care
emerging markets
clinical excellence
environmental allergies
gptkbp:has_a_mission_to improve patient quality of life
enhance treatment accessibility
gptkbp:has_expertise_in gptkb:France
gptkbp:has_partnerships_with pharmaceutical companies
various healthcare organizations
gptkbp:hasPrograms global expansion
innovation in treatments
gptkbp:headquarteredIn Lyon
gptkbp:headquarters gptkb:Lyon,_France
https://www.w3.org/2000/01/rdf-schema#label Stallergenes Group
gptkbp:is_a_member_of industry associations
gptkbp:is_committed_to sustainability
continuous improvement
ethical practices
safety and efficacy
gptkbp:is_displayed_on gptkb:Euronext_Paris
gptkbp:is_involved_in patient education
clinical trials
community outreach programs
international collaborations
regulatory compliance.
healthcare_policy_advocacy
gptkbp:is_known_for patient safety initiatives
high-quality standards
sublingual immunotherapy
gptkbp:is_part_of the healthcare industry
gptkbp:is_recognized_for scientific publications
healthcare_professionals
innovation in allergy treatment
gptkbp:offers allergen immunotherapy products
gptkbp:operates_in Europe
gptkbp:produces allergen extracts
gptkbp:provides diagnostic_services
gptkbp:providesTrainingFor healthcare_professionals
gptkbp:range immunotherapy products
gptkbp:receives regulatory approvals
gptkbp:specializesIn allergy immunotherapy
gptkbp:subsidiary gptkb:Stallergenes_Greer
gptkbp:targets allergic rhinitis
gptkbp:vision lead in allergy treatment